logo
Plus   Neg
Share
Email

DaVita Clinical Research To Conduct COVID-19 Studies In Dialysis Patients

DaVita Clinical Research, the research arm of DaVita Inc., has started enrollment on two trials to study how COVID-19 affects people with end stage kidney disease who are currently receiving dialysis. The study will be investigating presence of COVID-19 antibodies and genetic contributions to infection severity in patients. The results of both DCR COVID-19 studies are anticipated to be submitted for publication in early 2021.

"Our researchers are seeking to contribute to understanding COVID-19's impact on a patient population that has increased risk due to underlying medical conditions. These studies are particularly important to better forecast future COVID-19 outbreaks, minimize infections and, ultimately, save lives," said Amy Young, vice president of DCR.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Fast-food giant McDonald's said it will be raising hourly wages for more than 36,500 hardworking employees at McDonald's-owned restaurants by an average of 10 percent to make it among the industry-leading pay and benefits package. These increases, which have already begun, will be rolled out over the next several months. Biogen Inc. (BIIB) Friday said its XIRIUS study of cotoretigene toliparvovec failed to meet its primary endpoint in Phase 2/3 in patients with X-linked retinitis pigmentosa or XLRP. The company further noted that the study obtained positive trends in other pre-specified clinically relevant endpoints,... General Mills Inc. (GIS) agreed to buy Tyson Foods' (TSN) pet treats business for $1.2 billion in cash, the companies said in a statement on Friday. The transaction includes the Nudges, Top Chews and True Chews brands. General Mills will also acquire a manufacturing facility in Independence, Iowa.
RELATED NEWS
Follow RTT